Published : Dec-2019
No. of Pages : 155
1.1 List of Tables 7
1.2 List of Figures 11
2 Introduction 12
2.1 Point-of-Care (POC) Analyzers Overview 12
3 Products under Development 13
3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 13
3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory 14
3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 15
3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 16
3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 17
4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies 18
4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 18
4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 21
5 Point-of-Care (POC) Analyzers Companies and Product Overview 24
5.1 Access Bio Inc Company Overview 24
5.1.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.2 Acrongenomics Inc (Inactive) Company Overview 25
5.2.1 Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 AgPlus Diagnostics LTD Company Overview 26
5.3.1 AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Akers Biosciences Inc Company Overview 27
5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Akonni Biosystems Inc Company Overview 29
5.5.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 Alere Inc Company Overview 30
5.6.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Analytical Diagnostic Solutions Inc Company Overview 31
5.7.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 ApoCell Inc Company Overview 33
5.8.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Aptatek BioSciences Inc Company Overview 34
5.9.1 Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Atonomics A/S Company Overview 35
5.10.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 BBB Technologies Inc Company Overview 36
5.11.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 Binghampton University Company Overview 37
5.12.1 Binghampton University Pipeline Products & Ongoing Clinical Trials Overview 37
5.13 Bio-AMD Inc Company Overview 38
5.13.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 BioMedomics Inc Company Overview 39
5.14.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 Biopico Systems Inc Company Overview 40
5.15.1 Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 Biosensia Ltd Company Overview 41
5.16.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 Boston University Company Overview 42
5.17.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 BreviTest Technologies LLC Company Overview 43
5.18.1 BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Brigham and Women's Hospital Company Overview 44
5.19.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 Calmark Sweden AB Company Overview 45
5.20.1 Calmark Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Canon USA Inc Company Overview 47
5.21.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.22 CardioGenics Inc Company Overview 48
5.22.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.23 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Company Overview 49
5.23.1 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Pipeline Products & Ongoing Clinical Trials Overview 49
5.24 Cepheid Company Overview 51
5.24.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 ChipCare Corp Company Overview 54
5.25.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 54
5.26 City, University of London Company Overview 55
5.26.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 55
5.27 Co-Diagnostics Inc Company Overview 56
5.27.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.28 Cornell University Company Overview 57
5.28.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 57
5.29 Cutting Edge Medical Devices Limited Company Overview 58
5.29.1 Cutting Edge Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 58
5.30 Diagnostics For All Inc Company Overview 59
5.30.1 Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.31 Duke University Company Overview 60
5.31.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 60
5.32 EKF Diagnostics Holdings Plc Company Overview 61
5.32.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 61
5.33 Endeavor Sciences Inc Company Overview 62
5.33.1 Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 62
5.34 ExcitePCR Corp Company Overview 63
5.34.1 ExcitePCR Corp Pipeline Products & Ongoing Clinical Trials Overview 63
5.35 Exosome Diagnostics Inc Company Overview 64
5.35.1 Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 64
5.36 Fawkes Biotechnology LLC Company Overview 65
5.36.1 Fawkes Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview 65
5.37 First Light Diagnostics Inc Company Overview 66
5.37.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 66
5.38 Florida International University Company Overview 67
5.38.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 67
5.39 Future Diagnostics Solutions BV Company Overview 68
5.39.1 Future Diagnostics Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 68
5.40 Giner Inc Company Overview 69
5.40.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.41 GlucoSentient Inc Company Overview 70
5.41.1 GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 70
5.42 Indian Institute of Science Company Overview 71
5.42.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 71
5.43 Indian Institute of Technology Chennai Company Overview 72
5.43.1 Indian Institute of Technology Chennai Pipeline Products & Ongoing Clinical Trials Overview 72
5.44 Lucendi Inc Company Overview 73
5.44.1 Lucendi Inc Pipeline Products & Ongoing Clinical Trials Overview 73
5.45 Masaryk University Company Overview 74
5.45.1 Masaryk University Pipeline Products & Ongoing Clinical Trials Overview 74
5.46 Maxygen-mobile DNA tests Company Overview 75
5.46.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 75
5.47 mBio Diagnostics Inc Company Overview 76
5.47.1 mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 76
5.48 McKesson Corp Company Overview 78
5.48.1 McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 78
5.49 Meridian Bioscience Inc Company Overview 79
5.49.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 79
5.50 MML Ltd Company Overview 80
5.50.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
5.51 Molecular Warehouse Ltd Company Overview 81
5.51.1 Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.52 Nalia Systems Ltd Company Overview 82
5.52.1 Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
5.53 Newcastle University Company Overview 83
5.53.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 83
5.54 Nikkiso Co Ltd Company Overview 85
5.54.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
5.55 Ohmx Corp Company Overview 86
5.55.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 86
5.56 OncoGenesis Company Overview 87
5.56.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 87
5.57 Ontera Inc Company Overview 88
5.57.1 Ontera Inc Pipeline Products & Ongoing Clinical Trials Overview 88
5.58 Pacific Nanoscience, Inc. Company Overview 89
5.58.1 Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
5.59 POC Medical Systems Inc Company Overview 90
5.59.1 POC Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 90
5.60 ProciseDx LLC Company Overview 91
5.60.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview 91
5.61 Quanterix Corp Company Overview 92
5.61.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 92
5.62 Qvella Corp Company Overview 93
5.62.1 Qvella Corp Pipeline Products & Ongoing Clinical Trials Overview 93
5.63 Radisens Diagnostics Ltd Company Overview 94
5.63.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.64 Raman Diagnostics Ltd (Inactive) Company Overview 95
5.64.1 Raman Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95
5.65 RMIT University Company Overview 96
5.65.1 RMIT University Pipeline Products & Ongoing Clinical Trials Overview 96
5.66 SeLux Diagnostics Inc Company Overview 97
5.66.1 SeLux Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 97
5.67 SenGenix Inc Company Overview 99
5.67.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 99
5.68 StemTek Therapeutics SL Company Overview 100
5.68.1 StemTek Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 100
5.69 Thermal Gradient Inc Company Overview 101
5.69.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 101
5.70 Trinity Biotech Plc Company Overview 103
5.70.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 103
5.71 University of Calgary Company Overview 105
5.71.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 105
5.72 University of California Berkeley Company Overview 106
5.72.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 106
5.73 University of Glasgow Company Overview 109
5.73.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 109
5.74 University of Illinois at Chicago Company Overview 110
5.74.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 110
5.75 Wellstat Diagnostics LLC Company Overview 111
5.75.1 Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 111
6 Point-of-Care (POC) Analyzers- Recent Developments 112
6.1 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance 112
6.2 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 112
6.3 Oct 23, 2019: bioMerieux - Third-Quarter 2019 Business Review 114
6.4 Oct 22, 2019: bioMerieux - Third quarter 2019 business review 115
6.5 Oct 18, 2019: Calmark extends the time plan for CE-mark of the biomarkers LDH and Glucose - market launch as according to plan 117
6.6 Oct 18, 2019: McKesson's Board of Directors appoints Maria Martinez as new independent Director 117
6.7 Oct 16, 2019: BioDirection announces move of corporate headquarters to Southborough, Massachusetts 118
6.8 Oct 08, 2019: Results for Calmark's initial biomarker, bilirubin, are within the expected range - project enters verification and validation phase to obtain CE mark 119
6.9 Oct 02, 2019: Selux Diagnostics beats key contract milestone, receives $11.4m in additional funding 119
6.10 Sep 25, 2019: Dr. Joanne Spadoro Joins First Light Diagnostics 120
7 Appendix 152
7.1 Methodology 152
7.2 About GlobalData 155
7.3 Contact Us 155
7.4 Disclaimer 155
List of Tables
Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 14
Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 15
Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 16
Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 17
Table 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 18
Table 6: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 19
Table 7: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 22
Table 8: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 9: All-in-One Sensor - Product Status 25
Table 10: All-in-One Sensor - Product Description 25
Table 11: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
Table 12: BioLED Device - Diabetes Management - Product Status 27
Table 13: BioLED Device - Diabetes Management - Product Description 27
Table 14: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 28
Table 15: AgPlus Diagnostic System - Product Status 28
Table 16: AgPlus Diagnostic System - Product Description 28
Table 17: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 18: minDNAnalyzer - Product Status 29
Table 19: minDNAnalyzer - Product Description 30
Table 20: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 21: TruDx 2000 Platform - Product Status 31
Table 22: TruDx 2000 Platform - Product Description 31
Table 23: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 24: Clondiag HIV Molecular Device - Product Status 32
Table 25: Clondiag HIV Molecular Device - Product Description 32
Table 26: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 27: BiliNow - Product Status 33
Table 28: BiliNow - Product Description 33
Table 29: PKU Now - Product Status 34
Table 30: PKU Now - Product Description 34
Table 31: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 32: ApoStream System - Product Status 35
Table 33: ApoStream System - Product Description 35
Table 34: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 35: Point Of Care Diagnostic Device - Phenylketonuria - Product Status 36
Table 36: Point Of Care Diagnostic Device - Phenylketonuria - Product Description 36
Table 37: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 37
Table 38: Atolyzer PoC - Product Status 37
Table 39: Atolyzer PoC - Product Description 37
Table 40: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 41: markB - Product Status 38
Table 42: markB - Product Description 38
Table 43: Binghampton University Pipeline Products & Ongoing Clinical Trials Overview 40
Table 44: U-PAC - Product Status 40
Table 45: U-PAC - Product Description 40
Table 46: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 47: Magnetic Immunoassay Detection System - Product Status 42
Table 48: Magnetic Immunoassay Detection System - Product Description 42
Table 49: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 50: TR-LFIA Diagnostic Analyzer - Product Status 44
Table 51: TR-LFIA Diagnostic Analyzer - Product Description 44
Table 52: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 53: MONITOR System - Product Status 45
Table 54: MONITOR System - Product Description 45
Table 55: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Table 56: RapiPlex System - Product Status 46
Table 57: RapiPlex System - Product Description 46
Table 58: Boston University Pipeline Products & Ongoing Clinical Trials Overview 47
Table 59: Point-Of-Care Device - Allergen-Specific IgE - Product Status 47
Table 60: Point-Of-Care Device - Allergen-Specific IgE - Product Description 47
List of Figures
Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 13
Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 14
Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 15
Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 16
Figure 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 17
